Wells Fargo & Company Renalytix PLC Call Options Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RNLX
# of Institutions
29Shares Held
4.42MCall Options Held
0Put Options Held
0-
Gilder Gagnon Howe & CO LLC New York, NY761KShares$197,8880.01% of portfolio
-
Pinnacle Associates LTD696KShares$180,9610.01% of portfolio
-
Pentwater Capital Management LP Naples, FL630KShares$163,8000.01% of portfolio
-
Stifel Financial Corp St. Louis, MO558KShares$145,1840.0% of portfolio
-
Tejara Capital LTD London, X0500KShares$130,1020.16% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $9.74M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...